The Resistant Depression Response to Esketamine Assessing Metabolomics (ReDREAM) Project— Untargeted Metabolomics to Identify Biomarkers of Treatment Response to Intranasal Esketamine in Individuals with Treatment-Resistant Depression: A Study Protocol.

Autor: Bartoli, Francesco1, Cavaleri, Daniele1 d.cavaleri1@campus.unimib.it, Riboldi, Ilaria1, Crocamo, Cristina1, de Filippis, Renato2, Callegher, Riccardo Zandonella3, Paglia, Giuseppe1, Albert, Umberto3, De Fazio, Pasquale2, Carrà, Giuseppe1
Zdroj: Alpha Psychiatry. Aug2024, Vol. 25 Issue 4, p555-560. 6p.
Databáze: Academic Search Ultimate